The future trajectory of adverse outcome pathways: a commentary

被引:0
|
作者
Fiona Sewell
Nichola Gellatly
Maria Beaumont
Natalie Burden
Richard Currie
Lolke de Haan
Thomas H. Hutchinson
Miriam Jacobs
Catherine Mahony
Ian Malcomber
Jyotigna Mehta
Graham Whale
Ian Kimber
机构
[1] National Centre for the Replacement,School of Geography, Earth and Environmental Sciences
[2] Refinement and Reduction of Animals in Research (NC3Rs),Faculty of Biology, Medicine and Health
[3] GlaxoSmithKline,undefined
[4] Syngenta Ltd.,undefined
[5] Jealott’s Hill International Research Centre,undefined
[6] MedImmune,undefined
[7] University of Plymouth,undefined
[8] Public Health England,undefined
[9] Procter and Gamble Company,undefined
[10] Unilever,undefined
[11] Safety and Environmental Assurance Centre,undefined
[12] Dow AgroSciences,undefined
[13] European Development Centre,undefined
[14] Shell,undefined
[15] Health,undefined
[16] Shell Centre,undefined
[17] University of Manchester,undefined
来源
Archives of Toxicology | 2018年 / 92卷
关键词
Adverse outcome pathways (AOPs); Hazard identification; Safety assessment; Risk assessment;
D O I
暂无
中图分类号
学科分类号
摘要
The advent of adverse outcome pathways (AOPs) has provided a new lexicon for description of mechanistic toxicology, and a renewed enthusiasm for exploring modes of action resulting in adverse health and environmental effects. In addition, AOPs have been used successfully as a framework for the design and development of non-animal approaches to toxicity testing. Although the value of AOPs is widely recognised, there remain challenges and opportunities associated with their use in practise. The purpose of this article is to consider specifically how the future trajectory of AOPs may provide a basis for addressing some of those challenges and opportunities.
引用
收藏
页码:1657 / 1661
页数:4
相关论文
共 50 条
  • [21] Why Adverse Outcome Pathways Need to be FAIR
    Wittwehr, Clemens
    Clerbaux, Laure-Alix
    Edwards, Stephen
    Angrish, Michelle
    Mortensen, Holly
    Carusi, Annamaria
    Gromelski, Maciej
    Lekka, Eftychia
    Virvilis, Vassilis
    Martens, Marvin
    Santos, Luiz Olavo Bonino da Silva
    Nymark, Penny
    ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION, 2024, 41 (01) : 50 - 56
  • [22] Adverse outcome pathways: a concise introduction for toxicologists
    Vinken, Mathieu
    Knapen, Dries
    Vergauwen, Lucia
    Hengstler, Jan G.
    Angrish, Michelle
    Whelan, Maurice
    ARCHIVES OF TOXICOLOGY, 2017, 91 (11) : 3697 - 3707
  • [23] Adverse outcome pathways: a concise introduction for toxicologists
    Mathieu Vinken
    Dries Knapen
    Lucia Vergauwen
    Jan G. Hengstler
    Michelle Angrish
    Maurice Whelan
    Archives of Toxicology, 2017, 91 : 3697 - 3707
  • [24] Putative adverse outcome pathways relevant to neurotoxicity
    Bal-Price, Anna
    Crofton, Kevin M.
    Sachana, Magdalini
    Shafer, Timothy J.
    Behl, Mamta
    Forsby, Anna
    Hargreaves, Alan
    Landesmann, Brigitte
    Lein, Pamela J.
    Louisse, Jochem
    Monnet-Tschudi, Florianne
    Paini, Alicia
    Rolaki, Alexandra
    Schrattenholz, Andre
    Sunol, Cristina
    van Thriel, Christoph
    Whelan, Maurice
    Fritsche, Ellen
    CRITICAL REVIEWS IN TOXICOLOGY, 2015, 45 (01) : 83 - 91
  • [25] Integration of adverse outcome pathways with knowledge graphs
    Schultz, B. T.
    Wehr, M.
    Witters, H.
    Escher, S.
    Jacobs, M.
    TOXICOLOGY LETTERS, 2022, 368 : S85 - S85
  • [26] Taking adverse outcome pathways to the next level
    Vinken, Mathieu
    TOXICOLOGY IN VITRO, 2018, 50 : A1 - A2
  • [27] Quantitative Adverse Outcome Pathways and Their Application to Predictive Toxicology
    Conolly, Rory B.
    Ankley, Gerald T.
    Cheng, WanYun
    Mayo, Michael L.
    Miller, David H.
    Perkins, Edward J.
    Villeneuve, Daniel L.
    Watanabe, Karen H.
    ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2017, 51 (08) : 4661 - 4672
  • [28] Adverse outcome pathways for uranium induced kidney toxicity
    Gueguen, Y.
    TOXICOLOGY LETTERS, 2021, 350 : S70 - S71
  • [29] Adverse Outcome Pathways and Their Unifying Role in Developmental Toxicology
    Crofton, K. M.
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2013, 97 (05) : 277 - 277
  • [30] Searching for the adverse outcome pathways of polybrominated diphenyl ethers
    Cao, Lin-ying
    Guo, Liang-Hong
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256